RESEARCH-USE BIOSIMILAR ANTIBODY

Bentracimab

Monoclonal antibody · IgG1

AR-C124910XXIgG1RUO

Bentracimab (PB 2452) is a neutralizing monoclonal antibody that binds Ticagrelor (HY-1006) and its major active circulating metabolite with high affinity. Bentracimab can rapidly reverse the antiplatelet effect of Ticagrelor.

TARGETAR-C124910XX
YMonoclonal antibody
CATALOGSC-BS-731
CATALOG NUMBERSC-BS-731
MOLECULAR WEIGHTLot-specific
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Bentracimab (PB 2452) is a neutralizing monoclonal antibody that binds Ticagrelor (HY-1006) and its major active circulating metabolite with high affinity. Bentracimab can rapidly reverse the antiplatelet effect of Ticagrelor.

Bentracimab is a recombinant research-use antibody directed against AR-C124910XX.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Bentracimab | StellaCyte